Plus TherapeuticsCNSY
13F holders, Q3 2025 (September 30)23holders +4
10new positions
7sold out
$0.68avg. 13F price*
At the end of Q3 2025, 23 institutions reported holding Plus Therapeutics Inc. (CNSY) in their 13F filings, up 4 from Q2 2025. 10 opened new positions and 7 sold out. The largest holders were Vanguard Group Inc. ($990K), Altium Capital Management LLC ($628K) and Geode Capital Management, LLC ($556K).
- Company
- Plus Therapeutics Inc.
- CUSIP
- 72941H509
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $631K |
| Exits | 7 | $63K |
All 13F filers, Q2 2025 → Q3 2025: 4,101,254 shares bought and 183,548 shares sold, net +3,917,706 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| Vanguard Group Inc. | 0.00% | Add +4346.2% | 1,446,827 | $990K |
| Altium Capital Management LLC | 100.00% | — | 918,914 | $628K |
| Geode Capital Management, LLC | 0.00% | Add +1489.1% | 813,250 | $556K |
| UBS Group AG | 0.00% | Add +611.9% | 623,874 | $427K |
| BlackRock, Inc. | 0.00% | Add +6644.1% | 469,389 | $321K |
| State Street Corp. | 0.00% | New | 341,893 | $234K |
| Northern Trust Corp. | 0.00% | New | 265,489 | $182K |
| Scientech Research LLC | 0.03% | New | 146,654 | $100K |
| Susquehanna International Group, LLP | 0.00% | New | 67,264 | $46K |
| Mercer Global Advisors Inc. | 0.00% | New | 28,472 | $19K |
| Dagco, Inc. | 0.00% | New | 25,882 | $18K |
| Kestra Advisory Services, LLC | 0.00% | New | 25,800 | $18K |
| Cubist Systematic Strategies, LLC | 0.00% | Add +14.1% | 11,659 | $8K |
| Two Sigma Securities, LLC | 0.00% | New | 11,078 | $8K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | New | 10,500 | $7K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -41.8% | 3,520 | $2K |
| SBI Securities Co., Ltd. | 0.00% | Add +48.1% | 3,345 | $2K |
| Bank of America Corp. | 0.00% | Add +425.9% | 831 | $567 |
| Osaic Holdings, Inc. | 0.00% | No change | 133 | $59 |
| Wells Fargo & Company | 0.00% | Reduce -85.2% | 53 | $36 |
| Barclays PLC | 0.00% | Reduce -98.0% | 2 | $1 |
| Danske Bank A/S | 0.00% | No change | 1 | $1 |
| Group One Trading LLC | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is CNSY's weight in each manager's 13F, not the share of Plus Therapeutics Inc. the manager owns.